A Chinese company is developing non-invasive ultrasound brain-computer interfaces to treat chronic pain, intensifying competition in alternatives to surgical neural implants.
A major clinical trial shows wireless neural implants restored meaningful central vision to those blinded by macular degeneration, with participants reading letters and words.
New research reveals how targeting different brain regions with theta burst stimulation enhances motor imagery performance through separate mechanisms, offering potential solutions for stroke patients struggling with BCI control.
Cortical Labs demonstrated human brain cells on a chip mastering basic gameplay within seven days, advancing the case for biological computing in real-world applications.
Elon Musk's brain-computer interface company has now implanted 21 people with its neural device, marking a significant acceleration in its clinical trial timeline.
Chinese BCI company NeuroXess has surpassed human trial milestones, positioning itself as a direct competitor to Neuralink in the global neural interface market.
Brazilian neuroscientist Miguel Nicolelis leads research with Chinese collaborators demonstrating that brain-computer interface technology can trigger neural reorganization and restore movement in paralyzed patients.
Researchers demonstrate that individualized fMRI models can decode spontaneous pain in chronic pain patients, marking a shift toward objective, brain-based pain measurement that could reshape treatment and neurotech interventions.
The cryptocurrency giant's massive investment in one of the oldest BCI companies signals an unexpected collision between digital currency and neurotechnology sectors.